Acetylcholinesterase and Memantine for ASD

Two new protocols published for Cochrane Reviews (intervention) on autism spectrum disorders (ASD). One will assess the effects of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication and restrictive and repetitive behaviours) of ASD (read it here on the Cochrane Library); and the other, the effects of memantine on the core features of ASD including, but not limited to, social functioning, communication skills and stereotypical behaviours (read it here on the Cochrane Library).